Vivesto AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vivesto AB
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
/ 
Others were interested in
Frequently asked questions
To buy Vivesto AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vivesto AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vivesto AB is VIVE:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vivesto AB has its primary listing on NASDAQ OMX Stockholm. You can trade Vivesto AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vivesto AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vivesto AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vivesto AB.